Company Overview: Indegene Ltd is a technology led digital commercialization provider to the life science industry, including biopharmaceutical, emerging biotech and medical device companies. The company provides technology led expertise and capabilities that assists clients with drug development, clinical trials, regulatory submissions, pharmacovigilance, complaint management and sales & marketing services. Indegene operates across i) Enterprise […]
KPI Green Energy order book provides healthy revenue visibility for next 2-3 years. Buy for target price of ₹2219 (21% upside): SBI Securities
The company during the quarter has reported 58.6%/71.2%/35.5% YoY growth in Sales/EBIDTA/PAT to Rs 289.4 cr/Rs 92.9 cr/ Rs 43.0 cr respectively. The full year FY24 Sales/EBITDA/PAT were up 59.0%/61.6%/47.5% YoY to Rs 1,023.9 cr/ Rs 336.8 cr/ Rs 161.7 cr respectively. The EBITDA margin for FY24 remained stable at 32.9% up 51 bps YoY. The overall full year performance in terms of revenue and EBITDA were higher than our expectations, however profit marginally missed our expectation on account of higher interest costs
Zomato is priming the innovation engine & is the top pick in the Indian internet space. Buy for target price of ₹300 (63% upside): ICICI Securities
Zomato’s ability to ‘execute’ at scale is well recognised by investors. We believe the company is now gearing up to improve its credentials as an ‘innovator’. We note it has launched multiple new initiatives in the past 40 days which aim at improving customer experience or exploring adjacencies in its core ‘food delivery’ business.
Huhtamaki has embarked on ‘Project Parivartan’ & is on the verge of turnround. Buy for target price of ₹434 (41% upside): SMIFS
Huhtamaki India Ltd. One-offs impacted profitability in Q1, On the verge of a Turnaround, Upgrade to BUY The company reported good show excluding the one-offs. Revenue declined by ~8% YoY but grew by mere ~1% QoQ. Lower volumes on YoY basis impacted the topline. Gross margin expanded by 332bps YoY but declined by 44bps QoQ […]
Recent Comments